|Signatures of mutational processes in human cancer|
LB Alexandrov, S Nik-Zainal, DC Wedge, SAJR Aparicio, S Behjati, ...
Nature 500 (7463), 415-421, 2013
|Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy|
H Farmer, N McCabe, CJ Lord, ANJ Tutt, DA Johnson, TB Richardson, ...
Nature 434 (7035), 917-921, 2005
|Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers|
PC Fong, DS Boss, TA Yap, A Tutt, P Wu, M Mergui-Roelvink, P Mortimer, ...
New England Journal of Medicine 361 (2), 123-134, 2009
|Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013|
A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ...
Annals of oncology 24 (9), 2206-2223, 2013
|Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015|
AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ...
Annals of oncology 26 (8), 1533-1546, 2015
|Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial|
A Tutt, M Robson, JE Garber, SM Domchek, MW Audeh, JN Weitzel, ...
The Lancet 376 (9737), 235-244, 2010
|Landscape of somatic mutations in 560 breast cancer whole-genome sequences|
S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ...
Nature 534 (7605), 47-54, 2016
|Mutational processes molding the genomes of 21 breast cancers|
S Nik-Zainal, LB Alexandrov, DC Wedge, P Van Loo, CD Greenman, ...
Cell 149 (5), 979-993, 2012
|Hallmarks of'BRCAness' in sporadic cancers|
N Turner, A Tutt, A Ashworth
Nature reviews cancer 4 (10), 814-819, 2004
|The landscape of cancer genes and mutational processes in breast cancer|
PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ...
Nature 486 (7403), 400-404, 2012
|Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial|
MW Audeh, J Carmichael, RT Penson, M Friedlander, B Powell, ...
The lancet 376 (9737), 245-251, 2010
|The life history of 21 breast cancers|
S Nik-Zainal, P Van Loo, DC Wedge, LB Alexandrov, CD Greenman, ...
Cell 149 (5), 994-1007, 2012
|Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly (ADP-ribose) polymerase inhibition|
N McCabe, NC Turner, CJ Lord, K Kluzek, A Białkowska, S Swift, ...
Cancer research 66 (16), 8109-8115, 2006
|Triple negative tumours: a critical review|
JS Reis‐Filho, ANJ Tutt
Histopathology 52 (1), 108-118, 2008
|De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017|
G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ...
Annals of Oncology 28 (8), 1700-1712, 2017
|Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in BRCA Carrier Ovarian Cancer Correlating With Platinum-Free Interval|
PC Fong, TA Yap, DS Boss, CP Carden, M Mergui-Roelvink, C Gourley, ...
Journal of clinical oncology 28 (15), 2512-2519, 2010
|Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade|
S Loi, B Haibe-Kains, C Desmedt, F Lallemand, AM Tutt, C Gillet, P Ellis, ...
Journal of clinical oncology 25 (10), 1239-1246, 2007
|BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells|
G Molyneux, FC Geyer, FA Magnay, A McCarthy, H Kendrick, R Natrajan, ...
Cell stem cell 7 (3), 403-417, 2010
|HRDetect is a predictor of BRCA1 and BRCA2 deficiency based on mutational signatures|
H Davies, D Glodzik, S Morganella, LR Yates, J Staaf, X Zou, ...
Nature medicine 23 (4), 517-525, 2017
|3rd ESO–ESMO international consensus guidelines for advanced breast cancer (ABC 3)|
F Cardoso, A Costa, E Senkus, M Aapro, F André, CH Barrios, J Bergh, ...
The Breast 31, 244-259, 2017